Home›The Treatise›Chapters›Chapter 59
Tratado de Cirurgia da Coluna Vertebral
SECTION 7 • Other Spinal Diseases
Chapter59

RHEUMATOLOGIC DISEASES OF THE SPINE

Vancouver: Teixeira CEG, Yazbek MA, Sachetto Z📖 Pages: 777-782
Full reading of this chapter is available exclusively in the printed edition of the Treatise.
Sec. 7Other Spinal Diseases
Cap. 59Clinical Chapter
3authors
Português
Español
English
Referênciasscientific citations
📑

Chapter Summary

• Context: Axial back pain is extraordinarily common, but only a fraction of patients have an underlying inflammatory etiology. Identifying this subset is vital because axial spondyloarthritis (axSpA) is a chronic inflammatory disorder capable of causing persistent pain, progressive stiffness, functional limitation, and structural ankylosis. Its pathophysiology involves complex interactions between genetic predisposition (notably HLA-B27), environmental triggers, biomechanical stress, and immune activation centered at the entheses, where inflammation and pathological new bone formation occur in tandem. Diagnosis can be difficult because no single laboratory test or imaging modality independently confirms or excludes the disease. Clinical history, peripheral and extra-articular manifestations, HLA-B27, acute phase reactants, and sacroiliac imaging must be interpreted in context. MRI has enhanced the detection of active inflammation prior to radiographic damage, but carries risks of overinterpretation. This chapter emphasizes integrated diagnosis and multidisciplinary care between rheumatology, radiology, physical therapy, and spine surgery.
• Chapter Objective: Recognize the inflammatory pattern of axial spinal involvement with emphasis on axial spondyloarthritis; understand enthesis-centered pathophysiology; accurately interpret clinical features, laboratory markers, and radiographic/MRI findings of the sacroiliac joints; differentiate mimicking conditions; and understand conservative management principles and indications for surgical evaluation.
• Enthesis, inflammation, and new bone formationThe enthesis is the primary site of initial inflammatory cascade. In genetically predisposed individuals, biomechanical stress and environmental factors trigger immune activation and cytokine release. Persistent inflammation drives both subchondral bone erosions and subsequent new bone formation (syndesmophytes), explaining the co-occurrence of structural damage and progressive ankylosis in axSpA.
• The clinical pattern mattersInflammatory back pain typically features insidious onset before age 45, chronic duration, morning stiffness lasting >30 minutes, improvement with exercise, and lack of relief with rest. Table 59.1 compiles clinical criteria sets (ASAS, Calin, Berlin). Peripheral arthritis, enthesitis, and dactylitis, along with extra-articular features (anterior uveitis, psoriasis, inflammatory bowel disease), complete the spondyloarthritis spectrum.
• Physical examination and its limitationsMobility measurements (Schober test, chest expansion, occiput-to-wall distance) document functional restriction, but provocative sacroiliac joint tests lack sufficient sensitivity and specificity to confirm or exclude sacroiliitis. In advanced disease, postural abnormalities reflect rigid spinal ankylosis.
• Integrated diagnosisHLA-B27 increases post-test probability in appropriate clinical scenarios, but its absence does not exclude axSpA. Inflammatory markers (CRP, ESR) can be normal in up to 50% of active cases. Plain radiography of sacroiliac joints remains key for identifying structural damage (New York criteria, Figure 59.1 and Table 59.2). When clinical suspicion is high and radiographs are negative or equivocal, MRI can demonstrate active subchondral bone marrow edema (Figure 59.2, Table 59.3).
• Avoiding imaging overdiagnosisBone marrow edema alone does not automatically equate to axial spondyloarthritis. Mechanical stress, sports, osteitis condensans ilii, degenerative changes, and infection can produce similar findings. Sacroiliac MRI must be interpreted strictly in light of clinical context, lesion anatomical distribution (periarticular vs non-joint areas), and presence of accompanying structural lesions.
• TreatmentStructured exercise, physical therapy, and lifestyle modifications form the foundation across all stages. Pharmacological therapy, managed by rheumatologists, progresses from NSAIDs to biologic DMARDs (TNF inhibitors, IL-17 inhibitors) and targeted synthetic agents (JAK inhibitors) based on disease activity. Surgery is reserved for severe structural consequences: unstable fractures, fixed kyphotic deformities, or secondary neurological deficits.
• Clinical Application: In clinical practice, the first challenge is differentiating mechanical back pain from an inflammatory pattern. A young adult presenting with chronic low back pain, prolonged morning stiffness, and relief with activity warrants targeted investigation even if lumbar radiographs appear unremarkable. HLA-B27 and acute phase reactants should be interpreted as probabilistic tools rather than binary tests. Sacroiliac MRI interpretation requires caution: nonspecific bone marrow edema in runners or postpartum women should not be misdiagnosed as lifelong spondyloarthritis without clinical concordance. Early and accurate diagnosis enables the timely initiation of targeted physical therapy and anti-inflammatory or biologic therapy before irreversible syndesmophyte bridging occurs. When severe fixed deformity or spinal fractures occur, the spine surgeon joins an established multidisciplinary management plan, ensuring systemic inflammation is controlled perioperatively.
🏷️

Keywords

Preferred DeCS/MeSH Descriptors:
Axial SpondyloarthritisSpondylitis, AnkylosingSacroiliitisSpondylarthropathiesSacroiliac JointLow Back PainHLA-B27 AntigenMagnetic Resonance Imaging
⭐

Why this chapter matters

Most low back pain is mechanical, but failing to recognize inflammatory back pain can delay the diagnosis of a progressive, disabling disease by 7 to 10 years. Conversely, misinterpreting minor marrow edema on MRI can expose healthy individuals to unnecessary immunosuppressive therapies. This chapter strikes the essential balance, teaching clinicians to recognize the clinical phenotype of axial spondyloarthritis and utilize laboratory and imaging tests as complementary diagnostic components.

“The diagnosis of axial spondyloarthritis does not rely on a single laboratory marker or an isolated MRI slice. It requires the synthesis of inflammatory clinical phenotype, extra-articular features, genetics, acute phase reactants, and active or structural sacroiliac imaging findings. Early recognition combined with judicious MRI interpretation allows timely therapy before functional loss without converting benign incidental findings into lifelong overdiagnosis.”
✨

Chapter Highlights

🌐
Card 1 — Inflammatory Back Pain Has a Distinct Pattern
Clinical characteristics

Inflammatory back pain is not defined simply by severity. Age of onset (<45 years), insidious progression, morning stiffness, and improvement with exercise rather than rest differentiate it from mechanical pain.

🩺
Card 2 — Normal Labs Do Not Exclude axSpA
Probabilistic testing

Negative HLA-B27 or normal CRP/ESR does not rule out axial spondyloarthritis. Laboratory results must be contextualized within the overall clinical picture, extra-articular signs, and imaging.

📐
Card 3 — Beware of MRI Overinterpretation
Marrow edema context

Sacroiliac bone marrow edema can occur with trauma, childbirth, and mechanical degeneration. Anatomical distribution, deep subchondral localization, and clinical concordance are vital to prevent false-positive diagnoses.

📑

How to Cite this Chapter (Vancouver Format)

Official bibliographic indexing and citation guidelines
📖 Pages: 777-782Vancouver Style
Authors (Vancouver):Teixeira CEG, Yazbek MA, Sachetto Z

Teixeira CEG, Yazbek MA, Sachetto Z. Doenças reumáticas da coluna vertebral. In: Pudles E, Defino H, Risso M, editors. Tratado de Cirurgia da Coluna Vertebral (Treatise of Spine Surgery). 1st ed. Rio de Janeiro: Dilivros Editora; 2026. p. 777-782.

ISBN: 978-85-8053-292-0 • 1.ª Edição • Dilivros Editora
📚

Bibliographic References

1. Navarro-Compán V, Sepriano A, Capelusnik D, Baraliakos X. Axial spondyloarthritis. Lancet. 2025;405(10473):159-72.
2. Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthop. 2011;2(12):107.
3. Walsh JA, Magrey M. Clinical manifestations and diagnosis of axial spondyloarthritis. J Clin Rheumatol. 2020;27(8):e547.
4. Wolf J, França EB, Assunção AA. The burden of low back pain, rheumatoid arthritis, osteoarthritis, and gout and their respective attributable risk factors in Brazil: results of the GBD 2017 study. Rev Soc Bras Med Trop. 2022;55(Suppl 1).
5. Michelena X, López-Medina C, Marzo-Ortega H. Non-radiographic versus radiographic axSpA: what’s in a name? Rheumatology. 2020;59(Suppl 4):iv18-24.
6. Lassiter W, Bhutta BS, Allam AE. Inflammatory back pain. StatPearls. 2024.
7. Farley T, Stokke J, Goyal K, DeMicco R. Chronic low back pain: history, symptoms, pain mechanisms, and treatment. Life (Basel). 2024;14(7):812.
8. Schett G, Lories RJ, D’Agostino MA, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13(12):731-41.
9. Del Vescovo S, Venerito V, Iannone C, Lopalco G. Uncovering the underworld of axial spondyloarthritis. Int J Mol Sci. 2023;24(7):6463.
10. Sharip A, Kunz J. Understanding the pathogenesis of spondyloarthritis. Biomolecules. 2020;10(10):1461.
11. Sieper J, Van Der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784-8.
12. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237(24):2613-4.
13. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54(2):569-78.
14. López-Medina C, Moltó A, Dougados M. Peripheral manifestations in spondyloarthritis and their effect: an ancillary analysis of the ASAS-COMOSPA Study. J Rheumatol. 2020;47(2):211-7.
15. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl 2).
16. Lee A, Gupta M, Boyinepally K, Stokey PJ, Ebraheim NA. Sacroiliitis: a review on anatomy, diagnosis, and treatment. Adv Orthop. 2022;2022(1):3283296.
17. Laslett M, Aprill CN, McDonald B, Young SB. Diagnosis of sacroiliac joint pain: validity of individual provocation tests and composites of tests. Man Ther. 2005;10(3):207-18.
18. Resende GG, Saad CGS, Oliveira DCM, Sousa Bueno Filho JS, Sampaio-Barros PD, de Medeiros Pinheiro M. HLA-B27 positivity in a large miscegenated population of 5,389,143 healthy blood marrow donors in Brazil. Adv Rheumatol. 2023;63(1).
19. Mandl P, Navarro-Compán V, Terslev L, Aegerter P, Van Der Heijde D, D’Agostino MA, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74(7):1327-39.
20. Linden S Van Der, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-8.
21. Maksymowych WP, Lambert RGW, Østergaard M, Pedersen SJ, Machado PM, Weber U, et al. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2019;78(11):1550-8.
22. Baraliakos X, Østergaard M, Lambert RGW, Eshed I, Machado PM, Pedersen SJ, et al. MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2022;81(9):1243-51.
23. Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34.
24. Zakaryan A, Ginosyan K. Perioperative management of patients with ankylosing spondylitis undergoing spine surgery. Front Pharmacol. 2020;11:1017.
25. Goodman SM, Springer BD, Chen AF, Davis M, Fernandez DR, Figgie M, et al. Perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care Res (Hoboken). 2022;74(9):1399-408.
Episode 06 – Early-Onset Scoliosis
Scheduled Premiere
Exclusive Premiere • Wednesday, October 07 at 9:00 PM (BRT)
Wednesday, October 07 at 9:00 PM (BRT)
The live countdown will be activated on the eve of the premiere.

The full videocast will premiere automatically in this player on Wednesday, 10/07 at 6:00 PM (BRT).

Also premiering on Spotify
Treatise in Debate

Official videocast derived from the treatise chapters.

Episode 06 – Early-Onset Scoliosis

Lungs and the Growing Spine: thoracic development, C-EOS classification, and growth-friendly surgical techniques